0001401708-21-000146.txt : 20210514 0001401708-21-000146.hdr.sgml : 20210514 20210514163458 ACCESSION NUMBER: 0001401708-21-000146 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210512 FILED AS OF DATE: 20210514 DATE AS OF CHANGE: 20210514 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRAY R BRADLEY CENTRAL INDEX KEY: 0001575739 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35980 FILM NUMBER: 21925264 MAIL ADDRESS: STREET 1: 530 FAIRVIEW AVENUE NORTH STREET 2: SUITE 2000 CITY: SEATTLE STATE: WA ZIP: 98109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NanoString Technologies Inc CENTRAL INDEX KEY: 0001401708 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 200094687 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 530 FAIRVIEW AVENUE NORTH CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 206-378-6266 MAIL ADDRESS: STREET 1: 530 FAIRVIEW AVENUE NORTH CITY: SEATTLE STATE: WA ZIP: 98109 4 1 wf-form4_162102445859959.xml FORM 4 X0306 4 2021-05-12 0 0001401708 NanoString Technologies Inc NSTG 0001575739 GRAY R BRADLEY 530 FAIRVIEW AVENUE N SEATTLE WA 98109 1 1 0 0 President and CEO Common Stock 2021-05-12 4 M 0 19940 6.72 A 189743 D Common Stock 2021-05-12 4 S 0 11895 51.90 D 177848 D Common Stock 2021-05-12 4 S 0 12870 52.95 D 164978 D Common Stock 2021-05-12 4 S 0 5534 53.98 D 159444 D Common Stock 2021-05-12 4 S 0 2934 55.03 D 156510 D Common Stock 2021-05-12 4 S 0 100 55.70 D 156410 D Stock Option (right to buy) 6.72 2021-05-12 4 M 0 19940 6.72 D 2023-01-09 Common Stock 19940.0 25000 D The sales reported by Mr. Gray were effected pursuant to a Rule 10b5-1 trading plan adopted on September 15, 2020. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $51.46 to $52.46, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $52.47 to $53.47, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $53.51 to $54.47, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $54.52 to $55.47, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. The option is subject to an early exercise provision and is immediately exercisable. 1/48th of the shares subject to such Option shall vest on each monthly anniversary of January 10, 2013. /s/ Shannon Atchison, Attorney in Fact 2021-05-14